miR-579-3p controls melanoma progression and resistance to target therapy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-579-3p controls melanoma progression and resistance to target therapy
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 113, Issue 34, Pages E5005-E5013
Publisher
Proceedings of the National Academy of Sciences
Online
2016-08-09
DOI
10.1073/pnas.1607753113
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-425 inhibits melanoma metastasis through repression of PI3K-Akt pathway by targeting IGF-1
- (2015) Pei Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- Lin28B promotes melanoma growth by mediating a microRNA regulatory circuit
- (2015) Zhenfeng Zhang et al. CARCINOGENESIS
- Long-term outcome in BRAFV600E melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progression
- (2015) Igor Puzanov et al. EUROPEAN JOURNAL OF CANCER
- MITF Modulates Therapeutic Resistance through EGFR Signaling
- (2015) Zhenyu Ji et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma
- (2015) Luigi Fattore et al. Oncotarget
- Alternative Polyadenylation Allows Differential Negative Feedback of Human miRNA miR-579 on Its Host Gene ZFR
- (2015) Ludwig Christian Hinske et al. PLoS One
- Potential Therapeutic Strategies to Overcome Acquired Resistance to BRAF or MEK Inhibitors in BRAF Mutant Cancers
- (2015) Ryan B. Corcoran et al. Oncotarget
- Change or die: Targeting adaptive signaling to kinase inhibition in cancer cells
- (2014) Vito W. Rebecca et al. BIOCHEMICAL PHARMACOLOGY
- Regulation of p53 by Mdm2 E3 Ligase Function Is Dispensable in Embryogenesis and Development, but Essential in Response to DNA Damage
- (2014) Laura A. Tollini et al. CANCER CELL
- MITF in melanoma: mechanisms behind its expression and activity
- (2014) Mariusz L. Hartman et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact
- (2014) H. Rizos et al. CLINICAL CANCER RESEARCH
- Systemic treatment for BRAF-mutant melanoma: where do we go next?
- (2014) Alexander M Menzies et al. LANCET ONCOLOGY
- Clinical relevance of circulating cell-free microRNAs in cancer
- (2014) Heidi Schwarzenbach et al. Nature Reviews Clinical Oncology
- Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
- (2014) Georgina V. Long et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
- (2014) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adaptive resistance to RAF inhibitors in melanoma
- (2014) Curtis H. Kugel et al. Pigment Cell & Melanoma Research
- MicroRNAs in cancer: biomarkers, functions and therapy
- (2014) Josie Hayes et al. TRENDS IN MOLECULAR MEDICINE
- Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma
- (2014) Georgina V. Long et al. Nature Communications
- Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
- (2014) Judith Müller et al. Nature Communications
- A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors
- (2014) D. J. Konieczkowski et al. Cancer Discovery
- Restoring p53 Function in Human Melanoma Cells by Inhibiting MDM2 and Cyclin B1/CDK1-Phosphorylated Nuclear iASPP
- (2013) Min Lu et al. CANCER CELL
- Treatment of BRAF-Mutant Melanoma: The Role of Vemurafenib and Other Therapies
- (2013) S Jang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- AP-1/c-Jun transcription factors: Regulation and function in malignant melanoma
- (2013) Melanie Kappelmann et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3
- (2013) Ethan V. Abel et al. JOURNAL OF CLINICAL INVESTIGATION
- Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies
- (2013) Luigi Fattore et al. Journal of Translational Medicine
- Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
- (2013) Meghna Das Thakur et al. NATURE
- MicroRNAs and other non-coding RNAs as targets for anticancer drug development
- (2013) Hui Ling et al. NATURE REVIEWS DRUG DISCOVERY
- Caspase Functions in Cell Death and Disease
- (2013) D. R. McIlwain et al. Cold Spring Harbor Perspectives in Biology
- Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
- (2013) H. Shi et al. Cancer Discovery
- MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy
- (2012) M. F. Segura et al. CARCINOGENESIS
- MIRUMIR: an online tool to test microRNAs as biomarkers to predict survival in cancer using multiple clinical data sets
- (2012) A V Antonov et al. CELL DEATH AND DIFFERENTIATION
- The role of BRAF V600 mutation in melanoma
- (2012) Paolo A Ascierto et al. Journal of Translational Medicine
- Oncogenic B-Raf signaling in melanoma cells controls a network of microRNAs with combinatorial functions
- (2012) K L Couts et al. ONCOGENE
- Mechanisms of acquired resistance to ERK1/2 pathway inhibitors
- (2012) A S Little et al. ONCOGENE
- Combinatorial therapies to overcome B-RAF inhibitor resistance in melanomas
- (2012) Roger S Lo PHARMACOGENOMICS
- BRAF Inhibitors and Melanoma
- (2011) Keith T. Flaherty CANCER JOURNAL
- BioProfiling.de: analytical web portal for high-throughput cell biology
- (2011) A. V. Antonov NUCLEIC ACIDS RESEARCH
- Robust MicroRNA Stability in Degraded RNA Preparations from Human Tissue and Cell Samples
- (2010) M. Jung et al. CLINICAL CHEMISTRY
- MicroRNA Expression Profiles Associated with Mutational Status and Survival in Malignant Melanoma
- (2010) Stefano Caramuta et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Profiling and Discovery of Novel miRNAs from Formalin-Fixed, Paraffin-Embedded Melanoma and Nodal Specimens
- (2009) Zhihai Ma et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- miRo: a miRNA knowledge base
- (2009) A. Lagana et al. Database-The Journal of Biological Databases and Curation
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started